- Purpose of This Guideline
- Risk of Infection Following an Exposure to HIV
- Rationale for PEP and Evidence of PEP Effectiveness
- First Dose of PEP and Management of the Exposure Site
- Evaluating Exposure Risk
- Source HIV Status and Management
- Baseline Testing of the Exposed Individual
- Selecting and Initiating a 28-Day Course of PEP
- Counseling and Patient Education
- Providing PEP Medications and Other Services
- Follow-Up of the Exposed Individual
- Sequential HIV Testing and Laboratory Monitoring
- Management of Potential Exposure to Hepatitis B Virus
- Management of Potential Exposure to Hepatitis C Virus
- Appendix: Dosing of nPEP Medications for Pediatric Patients Who Weigh <40 kg and/or Cannot Swallow Tablets
- All Recommendations
- All Good Practices
- All Tables, Figures, and Boxes
- Supplementary Materials
